(Q83970802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

The subconjunctival use of cetuximab and bevacizumab in inhibition of corneal angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1 reference

1 reference

Selcuk Tunik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yusuf Nergiz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ugur Keklikci

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Murat Akkus

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

15 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

Graefe's Archive for Clinical and Experimental Ophthalmology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1161-1167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527313%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00417-012-2008-6

29 January 2020

exact match

0 references

cites work

VEGF-dependent conjunctivalization of the corneal surface

1 reference

12 December 2020

[Inhibition of angiogenesis in the anterior chamber of the eye]

1 reference

12 December 2020

Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

1 reference

12 December 2020

Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea

1 reference

12 December 2020

Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.

1 reference

12 December 2020

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

1 reference

12 December 2020

The biology of vascular endothelial growth factor

1 reference

12 December 2020

Snake Venom Vascular Endothelial Growth Factors (VEGFs) Exhibit Potent Activity through Their Specific Recognition of KDR (VEGF Receptor 2)

1 reference

12 December 2020

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma

1 reference

12 December 2020

Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone.

1 reference

12 December 2020

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer

1 reference

12 December 2020

Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture

1 reference

12 December 2020

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

1 reference

12 December 2020

Antiangiogenesis to treat cancer and intraocular neovascular disorders

1 reference

12 December 2020

Angiogenesis in life, disease and medicine

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

1 reference

12 December 2020

Bevacizumab for neovascular ocular diseases

1 reference

12 December 2020

Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.

1 reference

12 December 2020

Vascular-specific growth factors and blood vessel formation

1 reference

12 December 2020

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

1 reference

12 December 2020

The price tag on progress--chemotherapy for colorectal cancer

1 reference

12 December 2020

Interleukin-8. A corneal factor that induces neovascularization

1 reference

12 December 2020

The inhibitory effects of trastuzumab on corneal neovascularization

1 reference

12 December 2020

Subconjunctival bevacizumab for corneal neovascularization

1 reference

12 December 2020

Establishing a link between oncogenes and tumor angiogenesis

1 reference

12 December 2020

Angiogenesis in health and disease

1 reference

12 December 2020

Time Course of Angiogenesis and Lymphangiogenesis After Brief Corneal Inflammation

1 reference

12 December 2020

Expression of growth factors and growth factor receptors in capillary hemangioblastoma

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

12 December 2020

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

12 December 2020

Angiogenesis as a therapeutic target

1 reference

12 December 2020

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

1 reference

12 December 2020